CODX logo

CODX Co-Diagnostics, Inc.

NASDAQ · Biotechnology · Healthcare

$1.40
-0.09 (-6.04%)

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides…

Market Cap: $1.56Mco-dx.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
120
Aug 13Aug 13

Quote

Day Range
$1.36 – $1.47
52-Week Range
$1.26 – $46.50
Volume
$326.9K
Market Cap
$1.56M
50-Day Avg
$2.75
200-Day Avg
$4.48
Prev Close
$1.49
Open
$1.42

Valuation & Ratios

P/E Ratio
-0.14
EPS
$-35.25
P/B Ratio
0.33
P/S Ratio
10.83
Debt/Equity
0.06
Current Ratio
3.87
Dividend Yield
+0.0%
Gross Margin
+64.3%

Returns & Efficiency

Return on Equity
-227.3%
Return on Assets
-189.5%
FCF Yield
-442.4%
EV/EBITDA
0.08

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$622.5K$-46.90M$-35.25
2024$3.92M$-37.64M$-37.20
2023$6.81M$-35.33M$-36.00
2022$34.22M$-14.24M$-13.57
2021$97.89M$36.66M$38.10

Social Signal Score

70
5d
70
1 mentions
30d
70
1 mentions
60d
70
1 mentions
90d
70
1 mentions
news: 1

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $-2.85 per share

4of 7 quarters beat consensus

Typical surprise +8.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$-1.46 vs $-3.00beat
  • Thu, May 14$-4.06 vs $-3.75miss
  • Tue, Mar 31$-16.35 vs $-3.60miss
  • Thu, Nov 13$-4.80 vs $-5.71beat
  • Thu, Aug 14$-0.23 vs $-0.25beat
  • Thu, May 8$-0.24 vs $-0.33beat

Estimates and results for CODX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

CODXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsseekingalpha.com·1d ago·Positive

    Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript

    View source ↗